TGFB1 and prostate cancer: Exosomes released by prostate cancer cells under hypoxic conditions contain more TGFβ IL-6, TNFα, and MMP, TSG101, AKT, ILK1, and β-catenin (38), suggesting that they could differentially modulate recipient cells compared to exosomes from normal cells.